Inspection Record

Steri-Med Pharma Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-10-18 14 findingsMaterial and supplier controlAseptic processing and sterility assuranceOther quality systemEquipment and facilityComputer system validationStability and storageCleaning validationDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

The premises and/or the manufacturing process were inadequate for minimizing contamination of the drugs and/or materials during fabrication and/or packaging.

2Aseptic processing and sterility assurance

The company did not justify the hold time for sterilized components, containers, or equipment.

3Other quality system

The written specifications were inadequate.

4Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

5Other quality system

Yields and/or the reconciled quantities were not checked at appropriate stages.

6Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

7Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

8Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

9Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

10Deviation, CAPA, and investigation

When the particulate and microbiological limits were exceeded, the company's operating procedures did not prescribe an investigation and implementation of corrective actions. The airborne particle monitoring system was inadequate.

11Equipment and facility

The company did not design or maintain the premises and equipment to minimize microbial contamination and the number of airborne particles in clean areas.

12Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate. The company did not set appropriate alert and action limits for the results of particulate and microbiological monitoring.

13Other quality system

The written sanitation program for clean areas was inadequate.

14Other quality system

The written clothing standards for each environmental grade were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-10-18. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Steri-Med Pharma Inc. findings history — including this company's other documents Health Canada documents, 2022 Go to Findings search